CSX CSX

CSX reports Q3 2026 results

Form
10-Q
Filed
Importance
Notable
  1. Revenue: $4.02 billion for the three months ended Sep 30, 2026
  2. Net income: $1.05 billion for the three months ended Sep 30, 2026
  3. Diluted EPS: $0.57 for the three months ended Sep 30, 2026
  4. Cash and equivalents: $1.22 billion at Sep 30, 2026

Written from the 10-Q on EDGAR. AI can make mistakes. Check the filing.

Get an email when CSX files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

What changed since last quarter

2 new legal mentions

Compared with the 10-Q for the period ended Jun 30, 2026.

Key numbers from the XBRL in this filing and the previous one.
This filingPreviousChange QoQ
Revenue$4.02B$3.94B+2.1%
Operating income and margin$1.57B · 39.1%$1.51B · 38.3%+4.2%, margin +0.8 pts
Net income$1.05B$1B+5%
Operating cash flow$1.62B$1.33B+22%
Cash$1.22B$1.01B+21%
New legal mentions (2)
  • Briefing on the appeal is complete and oral argument is scheduled for December 11, 2026.
  • On September 10, 2026, DOJ, on behalf of EPA, lodged a separate proposed consent decree in the United States District Court for the District of New Jersey. +2 more paragraphs

Similar companies

Companies of similar size in SIC 4011 and related industry codes: the same peer list as the financial tables.

Data on this page was fetched . The filing on SEC.gov is the record.